Fry's Path Capital focuses on making patient investments in exceptional entrepreneurs and businesses, leveraging a multi-generational capital base. The firm typically invests in Series A, B, and C rounds, supporting companies with significant growth potential. Their investment approach is tailored to the needs of each client, primarily serving families and institutions with a long-term horizon.

Notable portfolio companies include Luminoah, which has raised $6 million, and Vitara Biomedical, with $75 million raised. Fry's Path Capital is led by key partners who bring a wealth of experience and a commitment to building durable portfolios. The firm offers comprehensive investment advisory services, including asset allocation strategies, to help clients achieve their financial goals over multiple generations.